Pediatrics Doctors in Garden City, KS Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Leo Altamirano, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3700

Dr. Michael W Shull, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3730

Dr. Lindsay Jeanne Byrnes, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3700

Nandhini Sehar, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3710    Fax: 620-275-3767

Dr. James T. Zauche, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3700

Ms. Rachel Tanya Boodram, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3730    Fax: 620-275-3767

Dr. Elizabeth A. Doyle, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3700

Dr. Stephen C Meyers, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3700    Fax: 620-275-3717

News Archive

Invacare announces its financial results for the quarter and nine months ended September 30, 2009

Invacare Corporation (NYSE: IVC) today announced its financial results for the quarter and nine months ended September 30, 2009.

FDA's determination of equivalency validates Neogen's rapid test for Salmonella enteritidis

Neogen Corporation today announced that its rapid test for Salmonella enteritidis (SE) has been determined by the U.S. Food and Drug Administration (FDA) to be equivalent to the FDA's traditional testing method in accuracy, precision, and sensitivity for detecting SE.

New technology could serve as more reliable model of amyotrophic lateral sclerosis

A new study published today demonstrates that a technology developed at the University of Central Florida could serve as a more reliable clinically-based model of amyotrophic lateral sclerosis (ALS) and a better screening tool for novel therapies than currently use preclinical models.

Cancer genetics pioneer, Bert Vogelstein, awarded the Breakthrough Prize in Life Sciences

Bert Vogelstein, M.D., co-director of the Ludwig Center at Johns Hopkins and a Howard Hughes Medical Institute investigator has been awarded the Breakthrough Prize in Life Sciences. He was selected for his landmark work in cancer genomics and tumor suppressor genes.

Read more Medical News

› Verified 5 days ago